Home / Share Price Target / Sundaram
Sundaram Multi Pap Share Price Target 2024, 2025, 2026 to 2039 With Charts
Sundaram Multi Pap Limited | |||
 | Symbol: SUNDARAM | ||
| Price: ₹2.48 | |||
| Exchange: NSE | |||
| Basic Materials -> Paper & Paper Products | |||
Show Table of Contents
Table of Contents
- 1: Sundaram Multi Pap Brief Company Overview
- 1.1: Sundaram Multi Paper Limited: A Leading Stationery Manufacturer in India
- 1.2: Sundaram Multi Pap Financial Performance
- 1.2.1: Is Sundaram Multi Pap A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Sundaram Multi Pap Share Price Target For 2024
- 2.1.1: Sundaram Multi Pap Share Price Target Table For 2024
- 2.1.2: Summary: Sundaram Multi Pap Share Price Prediction For 2024
- 2.2: Sundaram Multi Pap Share Price Target For 2025
- 2.2.1: Sundaram Multi Pap Share Price Target Table For 2025
- 2.2.2: Summary: Sundaram Multi Pap Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Sundaram Multi Pap Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Sundaram Multi Pap Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Sundaram Multi Pap Past Performance
Sundaram Multi Pap Brief Company Overview
Sundaram Multi Paper Limited: A Leading Stationery Manufacturer in India
Established in 1985, Sundaram Multi Paper Limited is a prominent designer, manufacturer, and marketer of paper stationery products in India. With a comprehensive product range catering to students and businesses, the company has earned a strong reputation in the industry.
Their diverse product portfolio includes exercise notebooks, long books, graph books, drawing sheets, office stationery, and educational content. The company markets its products under the well-known 'Sundaram' brand and exports them globally.
Sundaram Multi Paper Limited is committed to providing high-quality products and fostering customer satisfaction. Their commitment to innovation and excellence has made them a trusted choice in the educational and corporate stationery segments.
Sundaram Multi Pap Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 141.21 Crore | Market valuation of Sundaram Multi Pap's shares. |
| Revenue (TTM) | 127.54 Crore | Total revenue generated by Sundaram Multi Pap over the past twelve months. |
| Net Income (TTM) | -6.39 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -7.04% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -5.02% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -0.3% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 44.28 | Company's total debt divided by total shareholder equity. |
| Total Debt | 41.85 Crore | Sum of Sundaram Multi Pap's current & long-term financial obligations. |
| Total Cash | 7.16 Crore | Total amount of liquid funds available to Sundaram Multi Pap. |
| Beta | 0.43 | Beta is less than 1 indicating that the Sundaram Multi Pap's price is less volatile than the market. |
Is Sundaram Multi Pap A Good Buy For Long Term?
Sundaram Multi Pap, a small-cap stock, shows mixed financial performance. Its recent revenue dip and negative profit margin raise concerns. However, its positive returns over the past 3, 5, and 12 months indicate potential for long-term growth. While its debt remains a factor, its cash balance offers some stability. Overall, Sundaram Multi Pap may be considered an average buy for long-term investors willing to tolerate some risk.
To predict the Sundaram Multi Pap's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sundaram Multi Pap Share Price Target For 2024
The line chart displays the monthly closing prices of Sundaram Multi Pap with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sundaram Multi Pap shares in 2024, see the table below.
Sundaram Multi Pap Share Price Target Table For 2024
| Sundaram Multi Pap's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 2.68 (+8.06%) | Fibonacci Extension Level 123.6% |
| 2024 Target 2 | 2.65 (+6.85%) | Fibonacci Extension Level 100% |
| 2024 Target 1 | 2.61 (+5.24%) | Price Action: 22 Oct 2024 Low |
| Current Price | 2.48 | Sundaram Multi Pap's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 2.58 (+4.03%) | Price Action: Chart |
| Stop Loss 2 | 2.55 (+2.82%) | Price Action: Aug 2017 Low |
| Stop Loss 3 | 2.52 (+1.61%) | Fibonacci Retracement Level 98.6% |
Summary: Sundaram Multi Pap Share Price Prediction For 2024
In summary, Sundaram Multi Pap has declined by ₹-0.52, recording a notable -17.33% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Sundaram Multi Pap for 2024 predicts an additional rise of 5.24% to 8.06% by the end of 2024 with three potential targets T1: 2.61, T2: 2.65, T3: 2.68. Stop Loss at SL1: 2.58, SL2: 2.55, SL3: 2.52.
Sundaram Multi Pap has a 52-week high of ₹4.20, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹2.46, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Sundaram Multi Pap.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sundaram Multi Pap Share Price Target For 2025
The line chart displays the monthly closing prices of Sundaram Multi Pap with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sundaram Multi Pap shares in 2025, see the table below.
Sundaram Multi Pap Share Price Target Table For 2025
| Sundaram Multi Pap's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 3.79 (+52.82%) | Price Action: Chart |
| 2025 Target 2 | 3.72 (+50%) | Price Action: Chart |
| 2025 Target 1 | 3.68 (+48.38%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 2.48 | Sundaram Multi Pap's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 2.30 (-7.26%) | Price Action: Nov 2014 High |
| Stop Loss 2 | 2.25 (-9.28%) | Price Action: Nov 2015 High |
| Stop Loss 3 | 2.21 (-10.89%) | Price Action: Chart |
Summary: Sundaram Multi Pap Share Price Prediction For 2025
In summary, Sundaram Multi Pap has declined by ₹-0.52, recording a notable -17.33% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Sundaram Multi Pap for 2025 predicts an additional rise of 48.38% to 52.82% by the end of 2025 with three potential targets T1: 3.68, T2: 3.72, T3: 3.79. Stop Loss at SL1: 2.30, SL2: 2.25, SL3: 2.21.
Sundaram Multi Pap has a All-Time high of ₹270.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹2.46, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sundaram Multi Pap, we have created a specific page for that check here: Sundaram Multi Pap Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sundaram Multi Pap Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Sundaram Multi Pap share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 4.4% over the next 15 years.
For complete year by year Sundaram Multi Pap long term share price target from 2024, 2025 to 2039 check the below table.
Sundaram Multi Pap Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Sundaram Multi Pap Target | YoY Change % |
|---|---|---|
| 2024 | ₹2.48 | [Current Price] |
| 2024 | ₹3.36 | 35.48% |
| 2025 | ₹2.98 | -11.31% |
| 2026 | ₹3.32 | 11.4% |
| 2027 | ₹3.89 | 17.16% |
| 2028 | ₹4.47 | 14.91% |
| 2029 | ₹4.47 | 0% |
| 2030 | ₹3.9 | -12.76% |
| 2031 | ₹4.3 | 10.25% |
| 2032 | ₹4.97 | 15.58% |
| 2033 | ₹5.65 | 13.68% |
| 2034 | ₹5.59 | -1.07% |
| 2035 | ₹4.83 | -13.6% |
| 2036 | ₹5.27 | 9.1% |
| 2037 | ₹6.05 | 14.8% |
| 2038 | ₹6.82 | 12.72% |
| 2039 | ₹6.14 | -9.98% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sundaram Multi Pap Past Performance
- In 2010, Sundaram Multi Pap opening price was ₹16.32
- As of Thu 21 Nov 2024 the price stands at ₹2.48.
- This represents a Compound Annual Growth Rate (CAGR) of -11.81%.
- In 14 years, an investment of 10,000 would have become ₹1,518.67.
As we wrap up, we hope you like our study on Sundaram Multi Pap share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
